Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Article
Nature 453, 110-114 (13 April 2008) | doi:10.1038/nature06866;
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Professor / Associate Professor (Pharmaceutics / Pharmaceutical Analysis&quality Control)
- Alliance Institute of Advanced Pharmacy and Health Sciences
- Hyderabad 500038 India
Assistant or Associate Professor, Section of Anatomic Pathology
- The Medical College of Georgia
- Augusta, Georgia, USA
BCR|[ndash]|ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
The Philadelphia chromosome, a chromosomal abnormality that encodes BCR–ABL1, is the defining lesion of chronic myelogenous leukaemia (CML) and a subset of acute lymphoblastic leukaemia (ALL). To define oncogenic lesions that cooperate with BCR–ABL1 to induce ALL, we performed a genome-wide analysis of diagnostic leukaemia samples from 304 individuals with ALL, including 43 BCR–ABL1 B-progenitor ALLs and 23 CML cases.
&
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
